Johnson & Johnson Aktie

Johnson & Johnson für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 853260 / ISIN: US4781601046

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
17.04.2018 12:50:28

Johnson & Johnson Q1 adjusted earnings Beat Estimates

(RTTNews) - Johnson & Johnson (JNJ) released a profit for first quarter that fell from last year.

The company's bottom line totaled $4.37 billion, or $1.60 per share. This compares with $4.42 billion, or $1.61 per share, in last year's first quarter.

Excluding items, Johnson & Johnson reported adjusted earnings of $5.64 billion or $2.06 per share for the period.

Analysts had expected the company to earn $2.00 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 12.6% to $20.01 billion from $17.77 billion last year.

Johnson & Johnson earnings at a glance:

-Earnings (Q1): $5.64 Bln. vs. $5.04 Bln. last year. -EPS (Q1): $2.06 vs. $1.83 last year. -Analysts Estimate: $2.00 -Revenue (Q1): $20.01 Bln vs. $17.77 Bln last year.

-Guidance: Next quarter revenue guidance: $8.00 to $8.20 Full year revenue guidance: $81.0 to $81.8 Bln

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 151,60 0,26% Johnson & Johnson